IBDEI213 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33991,2)
 ;;=^5015601
 ;;^UTILITY(U,$J,358.3,33992,0)
 ;;=N17.9^^154^1721^5
 ;;^UTILITY(U,$J,358.3,33992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33992,1,3,0)
 ;;=3^AKI,Unspec
 ;;^UTILITY(U,$J,358.3,33992,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,33992,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,33993,0)
 ;;=R39.2^^154^1721^15
 ;;^UTILITY(U,$J,358.3,33993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33993,1,3,0)
 ;;=3^Pre-Renal Uremia
 ;;^UTILITY(U,$J,358.3,33993,1,4,0)
 ;;=4^R39.2
 ;;^UTILITY(U,$J,358.3,33993,2)
 ;;=^5019348
 ;;^UTILITY(U,$J,358.3,33994,0)
 ;;=N13.9^^154^1721^14
 ;;^UTILITY(U,$J,358.3,33994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33994,1,3,0)
 ;;=3^Obstructive and Reflux Uropathy,Unspec
 ;;^UTILITY(U,$J,358.3,33994,1,4,0)
 ;;=4^N13.9
 ;;^UTILITY(U,$J,358.3,33994,2)
 ;;=^5015589
 ;;^UTILITY(U,$J,358.3,33995,0)
 ;;=N13.1^^154^1721^11
 ;;^UTILITY(U,$J,358.3,33995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33995,1,3,0)
 ;;=3^Hydronephrosis w/ Ureteral Stricture NEC
 ;;^UTILITY(U,$J,358.3,33995,1,4,0)
 ;;=4^N13.1
 ;;^UTILITY(U,$J,358.3,33995,2)
 ;;=^5015576
 ;;^UTILITY(U,$J,358.3,33996,0)
 ;;=N13.2^^154^1721^10
 ;;^UTILITY(U,$J,358.3,33996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33996,1,3,0)
 ;;=3^Hydronephrosis w/ Renal and Ureteral Calculous Obstruction
 ;;^UTILITY(U,$J,358.3,33996,1,4,0)
 ;;=4^N13.2
 ;;^UTILITY(U,$J,358.3,33996,2)
 ;;=^5015577
 ;;^UTILITY(U,$J,358.3,33997,0)
 ;;=N13.30^^154^1721^13
 ;;^UTILITY(U,$J,358.3,33997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33997,1,3,0)
 ;;=3^Hydronephrosis,Unspec
 ;;^UTILITY(U,$J,358.3,33997,1,4,0)
 ;;=4^N13.30
 ;;^UTILITY(U,$J,358.3,33997,2)
 ;;=^5015578
 ;;^UTILITY(U,$J,358.3,33998,0)
 ;;=N13.39^^154^1721^12
 ;;^UTILITY(U,$J,358.3,33998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33998,1,3,0)
 ;;=3^Hydronephrosis,Other
 ;;^UTILITY(U,$J,358.3,33998,1,4,0)
 ;;=4^N13.39
 ;;^UTILITY(U,$J,358.3,33998,2)
 ;;=^5015579
 ;;^UTILITY(U,$J,358.3,33999,0)
 ;;=R33.9^^154^1721^16
 ;;^UTILITY(U,$J,358.3,33999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33999,1,3,0)
 ;;=3^Urinary Retention,Unspec
 ;;^UTILITY(U,$J,358.3,33999,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,33999,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,34000,0)
 ;;=I75.81^^154^1721^8
 ;;^UTILITY(U,$J,358.3,34000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34000,1,3,0)
 ;;=3^Atheroembolism of Kidney
 ;;^UTILITY(U,$J,358.3,34000,1,4,0)
 ;;=4^I75.81
 ;;^UTILITY(U,$J,358.3,34000,2)
 ;;=^328516
 ;;^UTILITY(U,$J,358.3,34001,0)
 ;;=R34.^^154^1721^7
 ;;^UTILITY(U,$J,358.3,34001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34001,1,3,0)
 ;;=3^Anuria and Oliguria
 ;;^UTILITY(U,$J,358.3,34001,1,4,0)
 ;;=4^R34.
 ;;^UTILITY(U,$J,358.3,34001,2)
 ;;=^5019333
 ;;^UTILITY(U,$J,358.3,34002,0)
 ;;=K76.7^^154^1721^9
 ;;^UTILITY(U,$J,358.3,34002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34002,1,3,0)
 ;;=3^Hepatorenal Syndrome
 ;;^UTILITY(U,$J,358.3,34002,1,4,0)
 ;;=4^K76.7
 ;;^UTILITY(U,$J,358.3,34002,2)
 ;;=^56497
 ;;^UTILITY(U,$J,358.3,34003,0)
 ;;=N00.0^^154^1722^8
 ;;^UTILITY(U,$J,358.3,34003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34003,1,3,0)
 ;;=3^Acute nephritic syndrome w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,34003,1,4,0)
 ;;=4^N00.0
 ;;^UTILITY(U,$J,358.3,34003,2)
 ;;=^5015491
 ;;^UTILITY(U,$J,358.3,34004,0)
 ;;=N00.1^^154^1722^7
 ;;^UTILITY(U,$J,358.3,34004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34004,1,3,0)
 ;;=3^Acute nephritic syndrome w/ focal and segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,34004,1,4,0)
 ;;=4^N00.1
 ;;^UTILITY(U,$J,358.3,34004,2)
 ;;=^5015492
